| 发明名称 |
AN EXTENDED RELEASE FORMULATION OF A DIRECT THROMBIN INHIBITOR |
| 摘要 |
<p>Extended release formulations of 3-fluoro-2-pyridylmethyl-3-(2,2-difluoro-2-(2-pyridyl)ethylamino)-6-chloropyrazin-2-one-1-acetamide (DPOC-4088) that provide for better control of blood plasma levels. The extended release formulations maintain substantially constant plasma levels of the active ingredient for at least about 16 hours and provide for once-daily dosing.</p> |
| 申请公布号 |
EP2780016(A4) |
申请公布日期 |
2015.08.05 |
| 申请号 |
EP20120848616 |
申请日期 |
2012.11.06 |
| 申请人 |
DIAKRON PHARMACEUTICALS, INC. |
发明人 |
RAMAKRISHNAN, SANKAR;VENKATESAN, ELUMALAI;SURYAKUMAR, JAYANTHI;ALLARD, STEPHANE |
| 分类号 |
A61K31/4965;A61K9/20;A61K31/497;A61P7/02 |
主分类号 |
A61K31/4965 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
